Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodulargenotype-phenotype correlation
R. Sprenger et al., Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodulargenotype-phenotype correlation, PHARMACOGEN, 10(6), 2000, pp. 557-565
Glutathione S-transferase theta enzyme activity involved in the metabolism
of toxic compounds is absent in approximately 20% of Caucasians due to a ho
mozygous deletion of GSTT1 (*O/O), Because the exact manner of the GSTT1 de
letion was unknown, current genotyping of GSTT1 was limited to detect the p
resence versus complete absence of the gene by a GSTT1-specific polymerase
chain reaction (PCR). Thus, heterozygous (*A/O) and homozygous (*A/A) sampl
es could not be discriminated. We have characterized the boundaries of the
deletion of the human glutathione S-transferase theta (GSTT1) gene: PCR map
ping and sequencing revealed a 54251 bp fragment including GSTT1 to be dele
ted from chromosome 22, most likely by a homologous recombination event bet
ween two highly homologous sequence stretches that flank GSTT1, Based on th
e knowledge of the GSTT1*O region, a PCR assay was devised for unambiguous
discrimination of homozygously deleted (*O/O), heterozygously (*A/O) and ho
mozygously GSTT1 carrying (*A/A) individuals. Genotyping of 180 samples of
a Caucasian population revealed that the deletion consists of one defined a
llele, whose distribution in the population fits the Hardy-Weinberg equilib
rium with observed 20% *O/O, 46% *A/O and 34% *A/A individuals. The number
of GSTT1*A alleles detected by this procedure correlated highly significant
with the enzyme activity in erythrocytes. Genotype-phenotype comparisons d
emonstrated a codominant type of inheritance by a gene-dose effect: samples
with two active alleles expressed a statistically significant higher enzym
atic activity compared to those with one null allele (P < 0.0001, ANOVA). P
harmacogenetics 10:557-565 (C) 2000 Lippincott Williams & Wilkins.